IL138249A0 - Qualitative diferential screening - Google Patents

Qualitative diferential screening

Info

Publication number
IL138249A0
IL138249A0 IL13824999A IL13824999A IL138249A0 IL 138249 A0 IL138249 A0 IL 138249A0 IL 13824999 A IL13824999 A IL 13824999A IL 13824999 A IL13824999 A IL 13824999A IL 138249 A0 IL138249 A0 IL 138249A0
Authority
IL
Israel
Prior art keywords
situation
originating
nucleic acids
cdna
identifying
Prior art date
Application number
IL13824999A
Other languages
English (en)
Original Assignee
Exonhit Therapeutics Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exonhit Therapeutics Sa filed Critical Exonhit Therapeutics Sa
Publication of IL138249A0 publication Critical patent/IL138249A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Sanitary Device For Flush Toilet (AREA)
  • Threshing Machine Elements (AREA)
  • Lock And Its Accessories (AREA)
  • Paper (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
IL13824999A 1998-03-11 1999-03-11 Qualitative diferential screening IL138249A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9802997A FR2775984B1 (fr) 1998-03-11 1998-03-11 Criblage differentiel qualitatif
PCT/FR1999/000547 WO1999046403A1 (fr) 1998-03-11 1999-03-11 Criblage differentiel qualitatif

Publications (1)

Publication Number Publication Date
IL138249A0 true IL138249A0 (en) 2001-10-31

Family

ID=9523928

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13824999A IL138249A0 (en) 1998-03-11 1999-03-11 Qualitative diferential screening

Country Status (13)

Country Link
US (1) US6251590B1 (de)
EP (2) EP1566453B1 (de)
JP (1) JP4527280B2 (de)
AT (1) ATE295426T1 (de)
AU (1) AU760656B2 (de)
CA (1) CA2323231C (de)
DE (1) DE69925253T2 (de)
DK (2) DK1062364T3 (de)
ES (2) ES2551441T3 (de)
FR (1) FR2775984B1 (de)
IL (1) IL138249A0 (de)
PT (2) PT1062364E (de)
WO (1) WO1999046403A1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6881571B1 (en) * 1998-03-11 2005-04-19 Exonhit Therapeutics S.A. Qualitative differential screening
US20030165931A1 (en) * 1998-03-11 2003-09-04 Bruno Tocque Qualitative differential screening
US20040241728A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of lung disease related gene transcripts in blood
US7473528B2 (en) * 1999-01-06 2009-01-06 Genenews Inc. Method for the detection of Chagas disease related gene transcripts in blood
US20050123938A1 (en) * 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
US20040248170A1 (en) * 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of hyperlipidemia related gene transcripts in blood
US20040248169A1 (en) * 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of obesity related gene transcripts in blood
US20050003394A1 (en) * 1999-01-06 2005-01-06 Chondrogene Limited Method for the detection of rheumatoid arthritis related gene transcripts in blood
US20040241726A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of allergies related gene transcripts in blood
US20040265868A1 (en) * 1999-01-06 2004-12-30 Chondrogene Limited Method for the detection of depression related gene transcripts in blood
AU1853600A (en) 1999-01-06 2000-07-24 Choong-Chin Liew Method for the detection of gene transcripts in blood and uses thereof
US20060134635A1 (en) * 2001-02-28 2006-06-22 Chondrogene Limited Method for the detection of coronary artery disease related gene transcripts in blood
US20070105121A1 (en) * 1999-01-06 2007-05-10 Chondrogene Limited Method for the detection of schizophrenia related gene transcripts in blood
US6960439B2 (en) 1999-06-28 2005-11-01 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
US6692916B2 (en) 1999-06-28 2004-02-17 Source Precision Medicine, Inc. Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
FR2798392B1 (fr) * 1999-09-13 2005-07-15 Exonhit Therapeutics Sa Marqueurs genetiques de la toxicite, preparation et utilisations
FR2798673B1 (fr) * 1999-09-16 2004-05-28 Exonhit Therapeutics Sa Methodes et compositions pour la detection d'evenements pathologiques
US7361488B2 (en) * 2000-02-07 2008-04-22 Illumina, Inc. Nucleic acid detection methods using universal priming
JP2002065259A (ja) * 2000-08-24 2002-03-05 Shinya Watanabe 核酸標識方法および核酸標識用キット
US7807447B1 (en) 2000-08-25 2010-10-05 Merck Sharp & Dohme Corp. Compositions and methods for exon profiling
US6713257B2 (en) * 2000-08-25 2004-03-30 Rosetta Inpharmatics Llc Gene discovery using microarrays
US6632610B2 (en) 2000-10-12 2003-10-14 Gensat S.A. Methods of identification and isolation of polynucleotides containing nucleic acid differences
US20020168354A1 (en) 2000-11-10 2002-11-14 Daria Mochly-Rosen psiepsilonRack peptide composition and method for protection against tissue damage due to ischemia
US7833779B2 (en) * 2001-07-25 2010-11-16 Jivan Biologies Inc. Methods and systems for polynucleotide detection
US7340349B2 (en) 2001-07-25 2008-03-04 Jonathan Bingham Method and system for identifying splice variants of a gene
FR2828693B1 (fr) 2001-08-14 2004-06-18 Exonhit Therapeutics Sa Nouvelle cible moleculaire de la neurotoxicite
US6964850B2 (en) 2001-11-09 2005-11-15 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
ES2289169T3 (es) 2001-12-05 2008-02-01 Sense Proteomic Limited Redes de proteinas para variantes alelicas y sus usos.
US20050112705A1 (en) * 2002-03-14 2005-05-26 Laurent Bracco Variants of human kallikrein-2 and kallikrein-3 and uses thereof
FR2837215A1 (fr) * 2002-03-14 2003-09-19 Exonhit Therapeutics Sa Variants de kallikrein-2 et kallikrein-3 humaines et leurs utilisations
US7393635B2 (en) * 2002-05-16 2008-07-01 Dna Polymerase Technology, Inc. Ribocloning: recombinant DNA construction using primers with ribo bases
GB0216629D0 (en) * 2002-07-17 2002-08-28 Pharma Gen S A Method to analyze polymeric nucleic acid sequence variations
FR2844713A1 (fr) * 2002-09-25 2004-03-26 Exonhit Therapeutics Sa Nouvelle cible de l'angiogenese et utilisations
GB0228557D0 (en) * 2002-12-06 2003-01-15 Pharma Gen S A Method to analyze polymeric nucleic acid sequence variations
FR2848573B1 (fr) * 2002-12-13 2005-04-08 Exonhit Therapeutics Sa Compositions et methodes pour la detection et le traitement de pathologies neurodegeneratives
FR2848569A1 (fr) * 2002-12-17 2004-06-18 Exonhit Therapeutics Sa Variants de kallikrein-2 et kallikrein-3 humaines et leurs utilisations
FR2851247B1 (fr) 2003-02-19 2007-06-29 Exonhit Therapeutics Sa Methodes et compositions pour le traitement de pathologies degeneratives oculaires
EP1636379A2 (de) 2003-06-26 2006-03-22 Exonhit Therapeutics S.A. Prostata-spezifische gene und deren verwendung als ziele für die therapie und diagnose von prostatakrebs
CA2535332A1 (en) * 2003-08-08 2005-02-24 Thomas Jefferson University Method for rapid identification of alternative splicing
CA2545098A1 (fr) * 2003-11-13 2005-06-02 Exonhit Therapeutics Sa Identification de marqueurs diagnostic pour les encephalopathies subaigues spongiformes transmissibles
FR2862314A1 (fr) * 2003-11-13 2005-05-20 Exonhit Therapeutics Sa Identification de marqueurs diagnostic pour les encephalopathies subaigues spongiformes transmissibles
FR2867485B1 (fr) * 2003-12-10 2008-02-22 Exonhit Therapeutics Sa Identification de marqueurs diagnostics pour les encephalopathies subaigues spongiformes transmissibles
EP1586587A1 (de) * 2004-04-16 2005-10-19 Exonhit Therapeutics SA Zusammensetzungen und Verfahren zum Nachweis der Angiogenese
US7569367B2 (en) 2005-09-07 2009-08-04 Roche Diagnostics Operations, Inc. Nucleic acid preparation from whole blood for use in diagnosis of transmissible spongiform encephalopathy
AU2007271232A1 (en) * 2006-07-03 2008-01-10 Exonhit Therapeutics Sa Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics
WO2008119767A2 (en) * 2007-03-30 2008-10-09 Oryzon Genomics, S. A. Method of nucleic acid analysis.
EP2287336A1 (de) 2009-07-31 2011-02-23 Exhonit Therapeutics SA Verfahren und Methoden zur Alzheimer-Diagnose
EP3034620A1 (de) 2014-12-17 2016-06-22 Diaxonhit Zusammensetzungen und Verfahren zur Diagnose von Schilddrüsenkrebs
FR3036287A1 (fr) 2015-05-19 2016-11-25 Univ Bordeaux Traitement et detection des trypanosomes
EP3211096A1 (de) 2016-02-26 2017-08-30 Prestizia Kombination von micrornas, welche die vorhersage der klinischen entwicklung von rektumkrebs ermöglichen

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01218590A (ja) * 1988-02-29 1989-08-31 Toa Nenryo Kogyo Kk 組換ワクチニアウイルスを用いたリンダペスト（牛疫）ウイルスワクチン
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
FR2664287A1 (fr) * 1990-07-03 1992-01-10 Inst Nat Sante Rech Med Nouveau polypeptide presentant une activite enzymatique, et gene codant pour ce polypeptide.
WO1994012631A1 (en) * 1992-11-20 1994-06-09 Isis Innovation Limited Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors
US5955272A (en) * 1993-02-26 1999-09-21 University Of Massachusetts Detection of individual gene transcription and splicing
US5521297A (en) * 1993-06-04 1996-05-28 Salk Institute Biotechnology/Industrial Associates Nucleic acids encoding human metabotropic glutamate receptors
US5688918A (en) * 1993-08-02 1997-11-18 Health Research, Inc. p53as protein and antibody therefor
US5679541A (en) * 1994-02-14 1997-10-21 California Institute Of Technology Programmed cell death antagonist protein
PH31414A (en) * 1994-02-24 1998-10-29 Boehringer Ingelheim Int Method of diagnosing cancer precancerous state, orsusceptibility to other forms of diseases by anal ysis of irf-1 specific rna in biopsy samples.
JPH09511400A (ja) * 1994-03-30 1997-11-18 ユニバーシティ オブ メリーランド アット ボルティモア 交互スプライシングによって生成されるヒトインターロイキン変異体
JP2001526522A (ja) * 1995-02-24 2001-12-18 スローン−ケタリング・インスティテュート・フォー・キャンサー・リサーチ 前立腺特異的膜抗原およびその使用
FR2732348B1 (fr) * 1995-03-31 1997-04-30 Rhone Poulenc Rorer Sa Systeme d'expression conditionnel
FR2736915B1 (fr) * 1995-07-19 1997-08-22 Rhone Poulenc Rorer Sa Variants de la proteine p53 et utilisations therapeutiques
AU2253397A (en) 1996-01-23 1997-08-20 Affymetrix, Inc. Nucleic acid analysis techniques
EP0937159A4 (de) 1996-02-08 2004-10-20 Affymetrix Inc Speziesbestimmung und phenotypische charakterisierung von mikroorganismen auf der basis eines chips
EP0791660A1 (de) * 1996-02-22 1997-08-27 Smithkline Beecham Corporation Neuer diagnostischer Marker für Spleissvarianten von Genen, verbunden mit neurologischen Funktionen
EP0806478A3 (de) * 1996-05-10 1999-06-09 Health Research, Inc. P53as Protein und Antikörper dafür
WO1997046679A1 (en) * 1996-06-03 1997-12-11 St. Jude Children's Research Hospital Cyclin-c variants, and diagnostic and therapeutic uses thereof
US6040426A (en) * 1996-06-05 2000-03-21 Bml, Inc. Human Th2 specific protein
US5958738A (en) * 1997-03-24 1999-09-28 Roche Diagnostics Corporation Procedure for subtractive hybridization and difference analysis
DE1063294T1 (de) * 1998-02-09 2003-06-26 Boehringer Ingelheim International Gmbh Dns oder gene, die an der parkinsonschen krankheit beteiligt sind

Also Published As

Publication number Publication date
EP1062364B1 (de) 2005-05-11
EP1566453A3 (de) 2009-11-18
EP1566453A2 (de) 2005-08-24
US6251590B1 (en) 2001-06-26
DE69925253T2 (de) 2006-02-09
WO1999046403A1 (fr) 1999-09-16
ES2243047T3 (es) 2005-11-16
AU2839999A (en) 1999-09-27
ATE295426T1 (de) 2005-05-15
EP1062364A1 (de) 2000-12-27
JP2002505887A (ja) 2002-02-26
EP1566453B1 (de) 2015-09-09
DK1062364T3 (da) 2005-09-05
ES2551441T3 (es) 2015-11-19
DK1566453T3 (en) 2015-11-09
JP4527280B2 (ja) 2010-08-18
CA2323231C (fr) 2011-06-21
CA2323231A1 (fr) 1999-09-16
DE69925253D1 (en) 2005-06-16
FR2775984A1 (fr) 1999-09-17
FR2775984B1 (fr) 2006-09-15
PT1062364E (pt) 2005-09-30
AU760656B2 (en) 2003-05-22
PT1566453E (pt) 2015-11-13

Similar Documents

Publication Publication Date Title
IL138249A0 (en) Qualitative diferential screening
Gross et al. Poising chromatin for transcription
Lawton et al. The flavin-containing monooxygenase enzymes expressed in rabbit liver and lung are products of related but distinctly different genes.
CA1340160C (en) Method and reagents for detecting nucleic acid sequences
Wang et al. De novo telomere addition by Tetrahymena telomerase in vitro
EP0945519A3 (de) Methoden zum Nachweis von Unterschiedlich exprimierten Genen
Arenas et al. Purification of a RNA debranching activity from HeLa cells.
CA2039517A1 (en) Dna probe signal amplification
WO1993014218A1 (en) Enzymatic rna molecules
Hirahara et al. cDNA cloning, genomic cloning, and tissue‐specific regulation of mouse cerebroside sulfotransferase
Kay et al. Catalysis of splicing-related reactions between dinucleotides by a ribozyme
AU7847798A (en) Fluorescent nucleotide analog hairpin formation for detection of nuclei c acid hybridization
Giachelli et al. Developmentally regulated cytochrome P-450IA1 expression in cultured rat vascular smooth muscle cells
AU7206498A (en) A method to clone mrnas and display of differentially expressed transcripts (dodet)
WO1997005276A3 (de) Verfahren zur sequenzierung durch oligomerhybridisierung
Press et al. Control of the expression of c-sis mRNA in human glioblastoma cells by phorbol ester and transforming growth factor β
EP0811696A3 (de) Verfahren zur Gewinnung von Nukleotidsequenzen durch "randomly primed" Amplifikation
ATE321062T1 (de) Verfahren zur herstellung endotoxinfreier nukleinsäuren
Chan et al. Site-directed chemical modification for probing DNA-protein interactions: Osmium tetroxide modification of the− 10 site of the lacUV5 promoter enhances open complex formation
Jiang et al. Characterization of gene localization and accessibility in DHFR‐amplified CHO cells
Igarashi et al. Studies on the Restoration of the Activities of Ribonucleases by Polyamines in the Presence of Various Ribonuclease Inhibitors
Michael et al. In vitro transcription of mutated Leishmania tarentolae spliced leader RNA genes approximates in vivo patterns
Komiyama et al. pH Profiles of the Kinetic Parameters and Photoinactivation of Ribonuclease from Rhizopus sp
Phillips et al. An in vitro transcription assay for probing drug-DNA interactions at individual drug sites
US20040219581A1 (en) pH dependent signaling DNA enzymes

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees